NRP1 and neoplasm: Although NRP1 mainly modulates axon guidance and angiogenesis processes, recent evidence highlights the potential role of NRP1 in tumor progression and therapeutic failure, arising as a potential prognostic biomarker and therapeutic target [7–9].